When SaMD Becomes the Trial Investigator: Regulating Autonomous Clinical-Decision Software in Decentralized Trials
The rise of AI-enabled Software as a Medical Device (SaMD) that makes real‑time eligibility and dosing decisions is reshaping decentralized…